1. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365–78. http://www.ncbi.nlm.nih.gov/pubmed/2666378.
2. Cutting SM. Bacillus probiotics. Food Microbiol. 2011;28:214–20. doi:10.1016/j.fm.2010.03.007.
3. Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev. 2000;64:548–72. http://www.ncbi.nlm.nih.gov/pubmed/10974126.
4. Casula G, Cutting SM. Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Env Microbiol. 2002;68:2344–52. http://www.ncbi.nlm.nih.gov/pubmed/11976107.
5. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect. 2005;11:958–66. doi:10.1111/j.1469-0691.2005.01228.x.
6. Porwal S, Lal S, Cheema S, Kalia VC. Phylogeny in aid of the present and novel microbial lineages: diversity in Bacillus. PLoS One. 2009;4:e4438. doi:10.1371/journal.pone.0004438.
7. Senesi S, Celandroni F, Tavanti A, Ghelardi E. Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy. Appl Env Microbiol. 2001;67:834–9. doi:10.1128/AEM.67.2.834-839.2001.
8. Ciffo F. Determination of the spectrum of antibiotic resistance of the “Bacillus subtilis” strains of Enterogermina. Chemioterapia. 1984;3:45–52. http://www.ncbi.nlm.nih.gov/pubmed/6442972.
9. Mazza P, Zani F, Martelli P. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll Chim Farm. 1992;131:401–8. http://www.ncbi.nlm.nih.gov/pubmed/1299263.
10. Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, et al. Characterization of two Bacillus probiotics. Appl Environ Microbiol. 1999;65:4288–91. http://www.ncbi.nlm.nih.gov/pubmed/10473456. Accessed 29 Apr 2018.
11. Lippolis R, Siciliano RA, Mazzeo MF, Abbrescia A, Gnoni A, Sardanelli AM, et al. Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains. Proteome Sci. 2013;11:28. doi:10.1186/1477-5956-11-28.
12. Ripert G, Racedo SM, Elie A-M, Jacquot C, Bressollier P, Urdaci MC. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins. Antimicrob Agents Chemother. 2016;60:3445–54. doi:10.1128/AAC.02815-15.
13. Lopetuso LR, Scaldaferri F, Franceschi F, Gasbarrini A. Bacillus clausii and gut homeostasis: state of the art and future perspectives. Expert Rev Gastroenterol Hepatol. 2016;:1–6. doi:10.1080/17474124.2016.1200465.
14. Pradhan B, Guha D, Ray P, Das D, Aich P. Comparative Analysis of the Effects of Two Probiotic Bacterial Strains on Metabolism and Innate Immunity in the RAW 264.7 Murine Macrophage Cell Line. Probiotics Antimicrob Proteins. 2016;8:73–84. doi:10.1007/s12602-016-9211-4.
15. Patrone V, Molinari P, Morelli L. Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan. Int J Food Microbiol. 2016;237:92–7. doi:10.1016/j.ijfoodmicro.2016.08.012.
16. Bozdogan B, Galopin S, Leclercq R. Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii. Appl Env Microbiol. 2004;70:280–4. http://www.ncbi.nlm.nih.gov/pubmed/14711653.
17. Marseglia GL, Tosca M, Cirillo I, Licari A, Leone M, Marseglia A, et al. Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study. Ther Clin Risk Manag. 2007;3:13–7. doi:10.2147/TCRM.2007.3.1.13.
18. Gian Luigi Marseglia, Mariangela Tosca, Ignazio Cirillo, Amelia Licari, Maddalena Leone, Alessia Marseglia, Anna Maria Castellazzi and GC. Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study. Ther Clin Risk Manag. 2007;3:13–7. https://www.dovepress.com/efficacy-of-bacillus-clausii-spores-in-the-prevention-of-recurrent-res-peer-reviewed-article-TCRM. Accessed 28 Apr 2018.
19. Lakshmi SG, Jayanthi N, Saravanan M, Ratna MS. Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic. Toxicol Reports. 2017;4:62–71. doi:10.1016/J.TOXREP.2016.12.004.
20. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ. 2007;335:340. doi:10.1136/bmj.39272.581736.55.
21. Auch AF, von Jan M, Klenk H-P, Göker M. Digital DNA-DNA hybridization for microbial species delineation by means of genome-to-genome sequence comparison. Stand Genomic Sci. 2010;2:117–34. doi:10.4056/sigs.531120.
22. Saising J, Dube L, Ziebandt A-K, Voravuthikunchai SP, Nega M, Götz F. Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2012;56:5804–10. doi:10.1128/AAC.01296-12.
23. Goldstein BP. Resistance to rifampicin: a review. J Antibiot. 2014;67:625–30. doi:10.1038/ja.2014.107.
24. Schwarz S, Kehrenberg C, It Doublet B, Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. 2004. doi:10.1016/j.femsre.2004.04.001.
25. Floch MH, Walker WA. Probiotics are considered nutritional supplements. J Clin Gastroenterol. 2011;45 Suppl:S107. doi:10.1097/MCG.0b013e3182317e74.
26. Navarre WW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999;63:174–229. http://www.ncbi.nlm.nih.gov/pubmed/10066836. Accessed 20 Jul 2018.
27. Cotter PD, Hill C. Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiol Mol Biol Rev. 2003;67:429–53, table of contents. doi:10.1128/MMBR.67.3.429-453.2003.
28. Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005;29:625–51. doi:10.1016/j.femsre.2004.09.003.
29. Azcarate-Peril MA, Altermann E, Hoover-Fitzula RL, Cano RJ, Klaenhammer TR. Identification and inactivation of genetic loci involved with Lactobacillus acidophilus acid tolerance. Appl Environ Microbiol. 2004;70:5315–22. doi:10.1128/AEM.70.9.5315-5322.2004.
30. Hagenbuch B, Dawson P. The sodium bile salt cotransport family SLC10. Pflugers Arch Eur J Physiol. 2004;447:566–70. doi:10.1007/s00424-003-1130-z.
31. Wong MH, Oelkers P, Craddock AL, Dawson PA. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem. 1994;269:1340–7. http://www.ncbi.nlm.nih.gov/pubmed/8288599. Accessed 20 Jul 2018.
32. Nachin L, Nannmark U, Nystrom T. Differential Roles of the Universal Stress Proteins of Escherichia coli in Oxidative Stress Resistance, Adhesion, and Motility. J Bacteriol. 2005;187:6265–72. doi:10.1128/JB.187.18.6265-6272.2005.
33. Seifart Gomes C, Izar B, Pazan F, Mohamed W, Mraheil MA, Mukherjee K, et al. Universal stress proteins are important for oxidative and acid stress resistance and growth of Listeria monocytogenes EGD-e in vitro and in vivo. PLoS One. 2011;6:e24965. doi:10.1371/journal.pone.0024965.
34. Ventura M, Canchaya C, Zink R, Fitzgerald GF, van Sinderen D. Characterization of the groEL and groES loci in Bifidobacterium breve UCC 2003: genetic, transcriptional, and phylogenetic analyses. Appl Environ Microbiol. 2004;70:6197–209. doi:10.1128/AEM.70.10.6197-6209.2004.
35. Susin MF, Baldini RL, Gueiros-Filho F, Gomes SL. GroES/GroEL and DnaK/DnaJ have distinct roles in stress responses and during cell cycle progression in Caulobacter crescentus. J Bacteriol. 2006;188:8044–53. doi:10.1128/JB.00824-06.
36. Veinger L, Diamant S, Buchner J, Goloubinoff P. The small heat-shock protein IbpB from Escherichia coli stabilizes stress-denatured proteins for subsequent refolding by a multichaperone network. J Biol Chem. 1998;273:11032–7. http://www.ncbi.nlm.nih.gov/pubmed/9556585. Accessed 20 Jul 2018.
37. Narberhaus F. Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol Mol Biol Rev. 2002;66:64–93; table of contents. http://www.ncbi.nlm.nih.gov/pubmed/11875128. Accessed 20 Jul 2018.
38. Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem. 1993;268:1517–20. http://www.ncbi.nlm.nih.gov/pubmed/8093612. Accessed 20 Jul 2018.
39. Fu X, Adams Z, Liu R, Hepowit NL, Wu Y, Bowmann CF, et al. Methionine Sulfoxide Reductase A (MsrA) and Its Function in Ubiquitin-Like Protein Modification in Archaea. MBio. 2017;8. doi:10.1128/mBio.01169-17.
40. Marshall B, Petrowski D, Levy SB, Summers AO. Inter- and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage. Proc Natl Acad Sci U S A. 1990;87:6609–13. doi:10.1073/pnas.87.17.6609.
41. Gibson MK, Forsberg KJ, Dantas G. Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology. ISME J. 2015;9:207–16. doi:10.1038/ismej.2014.106.
42. Gueimonde M, Sánchez B, G de Los Reyes-Gavilán C, Margolles A. Antibiotic resistance in probiotic bacteria. Front Microbiol. 2013;4:202. doi:10.3389/fmicb.2013.00202.
43. Martinez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother. 2000;44:1771–7. http://www.ncbi.nlm.nih.gov/pubmed/10858329. Accessed 29 Apr 2018.
44. Cotter PD, Hill C, Ross RP. What’s in a name? Class distinction for bacteriocins - Author reply. Nat Rev Microbiol. 2006;4. doi:DOI 10.1038/nrmicro1273-c2.
45. Heng NCK, Tagg JR. What’s in a name? Class distinction for bacteriocins. Nat Rev Microbiol. 2006;4. doi:DOI 10.1038/nrmicro1273-c1.
46. Field D, Cotter PD, Hill C, Ross RP. Bioengineering Lantibiotics for Therapeutic Success. Front Microbiol. 2015;6:1363. doi:10.3389/fmicb.2015.01363.
47. McAuliffe O, Ryan MP, Ross RP, Hill C, Breeuwer P, Abee T. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol. 1998;64:439–45. http://www.ncbi.nlm.nih.gov/pubmed/9464377. Accessed 29 Apr 2018.
48. Masuda Y, Ono H, Kitagawa H, Ito H, Mu F, Sawa N, et al. Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401. Appl Environ Microbiol. 2011;77:8164–70. doi:10.1128/AEM.06348-11.
49. Shelburne CE, An FY, Dholpe V, Ramamoorthy A, Lopatin DE, Lantz MS. The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemother. 2006;59:297–300. doi:10.1093/jac/dkl495.
50. Liu Z, Budiharjo A, Wang P, Shi H, Fang J, Borriss R, et al. The highly modified microcin peptide plantazolicin is associated with nematicidal activity of Bacillus amyloliquefaciens FZB42. Appl Microbiol Biotechnol. 2013;97:10081–90. doi:10.1007/s00253-013-5247-5.
51. Kawai Y, Kemperman R, Kok J, Saito T. The circular bacteriocins gassericin A and circularin A. Curr Protein Pept Sci. 2004;5:393–8. http://www.ncbi.nlm.nih.gov/pubmed/15544534. Accessed 29 Apr 2018.
52. Kemperman R, Kuipers A, Karsens H, Nauta A, Kuipers O, Kok J. Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574. Appl Environ Microbiol. 2003;69:1589–97. doi:10.1128/AEM.69.3.1589-1597.2003.
53. Begley M, Cotter PD, Hill C, Ross RP. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol. 2009;75:5451–60. doi:10.1128/AEM.00730-09.
54. Simmonds RS, Pearson L, Kennedy RC, Tagg JR. Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol. 1996;62:4536–41. http://www.ncbi.nlm.nih.gov/pubmed/8953725. Accessed 29 Apr 2018.
55. Liu W-T, Yang Y-L, Xu Y, Lamsa A, Haste NM, Yang JY, et al. Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of Bacillus subtilis. Proc Natl Acad Sci U S A. 2010;107:16286–90. doi:10.1073/pnas.1008368107.
56. González-Pastor JE, Hobbs EC, Losick R. Cannibalism by sporulating bacteria. Science. 2003;301:510–3. doi:10.1126/science.1086462.
57. Lin D, Qu LJ, Gu H, Chen Z. A 3.1-kb genomic fragment of Bacillus subtilis encodes the protein inhibiting growth of Xanthomonas oryzae pv. oryzae. J Appl Microbiol. 2001;91:1044–50. http://www.ncbi.nlm.nih.gov/pubmed/11851812. Accessed 29 Apr 2018.
58. Rossi M, Amaretti A, Raimondi S. Folate Production by Probiotic Bacteria. Nutrients. 2011;3:118–34. doi:10.3390/nu3010118.
59. Zhu T, Pan Z, Domagalski N, Koepsel R, Ataai MM, Domach MM. Engineering of Bacillus subtilis for enhanced total synthesis of folic acid. Appl Environ Microbiol. 2005;71:7122–9. doi:10.1128/AEM.71.11.7122-7129.2005.
60. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27:29–34. http://www.ncbi.nlm.nih.gov/pubmed/9847135. Accessed 30 Jul 2017.
61. de Crécy-Lagard V. Variations in metabolic pathways create challenges for automated metabolic reconstructions: Examples from the tetrahydrofolate synthesis pathway. Comput Struct Biotechnol J. 2014;10:41–50. doi:10.1016/j.csbj.2014.05.008.
62. Salem AR, Pattison JR, Foster MA. Folic acid and the methylation of homocysteine by Bacillus subtilis. Biochem J. 1972;126:993–1004. http://www.ncbi.nlm.nih.gov/pubmed/4627401. Accessed 20 Jul 2018.
63. Khatri I, Sharma S, Ramya TNC, Subramanian S. Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics. PLoS One. 2016;11:e0156745. doi:10.1371/journal.pone.0156745.
64. Casanovas-Massana A, Sala-Comorera L, Blanch AR. Quantification of tetracycline and chloramphenicol resistance in digestive tracts of bulls and piglets fed with Toyocerin®, a feed additive containing Bacillus toyonensis spores. Vet Microbiol. 2014;173:59–65. doi:10.1016/J.VETMIC.2014.07.005.
65. Zhang S, Hu Y, Fan Q, Wang X, He J. Two-component system YvqEC-dependent bacterial resistance against vancomycin in Bacillus thuringiensis. Antonie Van Leeuwenhoek. 2015;108:365–76. doi:10.1007/s10482-015-0489-0.
66. Abriouel H, Franz CMAP, Omar N Ben, Gálvez A. Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev. 2011;35:201–32. doi:10.1111/j.1574-6976.2010.00244.x.
67. Chin CS, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods. 2013;10:563–9. doi:10.1038/nmeth.2474.
68. Urdaci MC, Bressollier P, Pinchuk I. Bacillus clausii Probiotic Strains. J Clin Gastroenterol. 2004;38 Supplement 2:S86–90. doi:10.1097/01.mcg.0000128925.06662.69.
69. Gargis AS, O’Rourke A-LD, Sloan GL, Simmonds RS. Prevalence and acquisition of the genes for zoocin A and zoocin A resistance in Streptococcus equi subsp. zooepidemicus. J Mol Evol. 2009;68:498–505. doi:10.1007/s00239-009-9221-x.
70. Williams LD, Burdock GA, Jiménez G, Castillo M. Literature review on the safety of Toyocerin®, a non-toxigenic and non-pathogenic Bacillus cereus var. toyoi preparation. Regul Toxicol Pharmacol. 2009;55:236–46. doi:10.1016/J.YRTPH.2009.07.009.
71. Fuchs CS, Willett WC, Colditz GA, Hunter DJ, Stampfer MJ, Speizer FE, et al. The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev. 2002;11:227–34. http://www.ncbi.nlm.nih.gov/pubmed/11895870. Accessed 19 Jul 2018.
72. White E, Shannon JS, Patterson RE, Hunter DJ, Stampfer MJ, Speizer FE, et al. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:769–74. http://www.ncbi.nlm.nih.gov/pubmed/9332757. Accessed 19 Jul 2018.
73. Schallmey M, Singh A, Ward OP. Developments in the use of Bacillus species for industrial production. Can J Microbiol. 2004;50:1–17. doi:10.1139/w03-076.
74. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST Server: Rapid Annotations using Subsystems Technology. BMC Genomics. 2008;9:75. doi:10.1186/1471-2164-9-75.
75. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, et al. The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res. 2014;42 Database issue:D206-14. doi:10.1093/nar/gkt1226.
76. Lowe TM, Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997;25:955–64. http://www.ncbi.nlm.nih.gov/pubmed/9023104. Accessed 30 Jul 2017.
77. Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, Rognes T, Ussery DW. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007;35:3100–8. doi:10.1093/nar/gkm160.
78. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, Yu Y, et al. Basic local alignment search tool. J Mol Biol. 1990;215:403–10. doi:10.1016/S0022-2836(05)80360-2.
79. Antipov D, Hartwick N, Shen M, Raiko M, Lapidus A, Pevzner PA. plasmidSPAdes: assembling plasmids from whole genome sequencing data. Bioinformatics. 2016;32:btw493. doi:10.1093/bioinformatics/btw493.
80. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7. doi:10.1093/nar/gkh340.
81. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30:1312–3. doi:10.1093/bioinformatics/btu033.
82. Tatusov RL, Fedorova ND, Jackson JD, Jacobs AR, Kiryutin B, Koonin E V, et al. The COG database: an updated version includes eukaryotes. BMC Bioinformatics. 2003;4:41. doi:10.1186/1471-2105-4-41.
83. Eddy SR. Hidden Markov models. Curr Opin Struct Biol. 1996;6:361–5. http://www.ncbi.nlm.nih.gov/pubmed/8804822.
84. Eddy SR. Accelerated Profile HMM Searches. PLoS Comput Biol. 2011;7:e1002195. doi:10.1371/journal.pcbi.1002195.
85. McArthur AG, Waglechner N, Nizam F, Yan A, Azad MA, Baylay AJ, et al. The comprehensive antibiotic resistance database. Antimicrob Agents Chemother. 2013;57:3348–57. doi:10.1128/AAC.00419-13.
86. van Heel AJ, de Jong A, Montalbán-López M, Kok J, Kuipers OP. BAGEL3: Automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides. Nucleic Acids Res. 2013;41 Web Server issue:W448-53. doi:10.1093/nar/gkt391.
87. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004;32:277D – 280. doi:10.1093/nar/gkh063.